These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19. Tiwari S; Goel G; Kumar A Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 immunity in animal models. Chen Z; Yuan Y; Hu Q; Zhu A; Chen F; Li S; Guan X; Lv C; Tang T; He Y; Cheng J; Zheng J; Hu X; Zhao J; Zhao J; Sun J Cell Mol Immunol; 2024 Feb; 21(2):119-133. PubMed ID: 38238440 [TBL] [Abstract][Full Text] [Related]
4. Review of selected animal models for respiratory coronavirus infection and its application in drug research. Qin S; Li R; Zheng Z; Zeng X; Wang Y; Wang X J Med Virol; 2022 Jul; 94(7):3032-3042. PubMed ID: 35285034 [TBL] [Abstract][Full Text] [Related]
5. Animal models for SARS-CoV-2. Lee CY; Lowen AC Curr Opin Virol; 2021 Jun; 48():73-81. PubMed ID: 33906125 [TBL] [Abstract][Full Text] [Related]
6. Animal Models of COVID-19 II. Comparative Immunology. Veenhuis RT; Zeiss CJ ILAR J; 2021 Dec; 62(1-2):17-34. PubMed ID: 33914873 [TBL] [Abstract][Full Text] [Related]
7. Animals and SARS-CoV-2: Species susceptibility and viral transmission in experimental and natural conditions, and the potential implications for community transmission. Hobbs EC; Reid TJ Transbound Emerg Dis; 2021 Jul; 68(4):1850-1867. PubMed ID: 33091230 [TBL] [Abstract][Full Text] [Related]
8. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium. Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888 [TBL] [Abstract][Full Text] [Related]
9. An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development. Zhang L; Chen S; Zhang W; Yang H; Jin Y; Duan G Front Microbiol; 2021; 12():770935. PubMed ID: 34819926 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
11. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus. Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775 [TBL] [Abstract][Full Text] [Related]
12. Animal models and SARS-CoV-2-induced pulmonary and neurological injuries. Pinto MA; da Silva ADS; Rodrigues DDRF; Müller R; de Vasconcelos GALBM; Neves PCDC; de Oliveira JM; Marchevsky RS Mem Inst Oswaldo Cruz; 2023; 117():e220239. PubMed ID: 36700583 [TBL] [Abstract][Full Text] [Related]
13. Animal models for SARS-CoV-2 infection and pathology. Bi Z; Hong W; Yang J; Lu S; Peng X MedComm (2020); 2021 Dec; 2(4):548-568. PubMed ID: 34909757 [TBL] [Abstract][Full Text] [Related]
14. Animal Models for the Study of SARS-CoV-2-Induced Respiratory Disease and Pathology. Dillard JA; Martinez SA; Dearing JJ; Montgomery SA; Baxter VK Comp Med; 2023 Feb; 73(1):72-90. PubMed ID: 36229170 [TBL] [Abstract][Full Text] [Related]
15. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis. Stevenson M; Metry A; Messenger M Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295 [TBL] [Abstract][Full Text] [Related]
16. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis. Kang YW; Park S; Lee KJ; Moon D; Kim YM; Lee SW Immune Netw; 2021 Feb; 21(1):e1. PubMed ID: 33728094 [TBL] [Abstract][Full Text] [Related]
17. SARS CoV-2 infections in animals, two years into the pandemic. Frazzini S; Amadori M; Turin L; Riva F Arch Virol; 2022 Dec; 167(12):2503-2517. PubMed ID: 36207554 [TBL] [Abstract][Full Text] [Related]
18. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern Spain. Fernández-Bastit L; Marfil S; Pradenas E; Valle R; Roca N; Rodon J; Pailler-García L; Trinité B; Parera M; Noguera-Julian M; Martorell J; Izquierdo-Useros N; Carrillo J; Clotet B; Blanco J; Vergara-Alert J; Segalés J Transbound Emerg Dis; 2022 Nov; 69(6):3518-3529. PubMed ID: 36167932 [TBL] [Abstract][Full Text] [Related]